Sort
85,873 grants matching “alzheimers”
The Human Genome Sequencing Center
$6,233,070Richard A Gibbs · Baylor College Of Medicine · U54 · FY2012 · HG
Educational and Early Life Predictors of Mild Cognitive Impairment: New Evidence about Mediators and Moderators from High School & Beyond
$6,228,064John Robert Warren · University Of Minnesota · R01 · FY2020 · AG
Discovery and validation of genetic variants affecting microglial activation in Alzheimer's disease
$6,213,164Philip L De Jager · Columbia University Health Sciences · RF1 · FY2020 · AG
Defining the effect of Alzheimer pathologies on the aged brain in 3 dimensions
$6,207,555Philip L De Jager · Columbia University Health Sciences · U19 · FY2025 · AG
Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa
$6,186,533Vaatausili T Tofaeono · American Samoa Community Cancer Coalitio · RF1 · FY2022 · AG
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
$6,178,080Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2021 · AG
Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium
$6,176,205Timothy J Hohman · Vanderbilt University Medical Center · U24 · FY2023 · AG
ALZHEIMERS RESEARCH PROJECT: Investigating Early and Cell-Autonomous Mechanisms of Neurodegeneration Using Human Brain Organoids
$6,167,741Elise Marsan · National Institute On Aging · ZIA · FY2025 · AG
The IU/JAX Alzheimer's Disease Precision Models Center
$6,158,485Bruce T Lamb · Indiana University Indianapolis · U54 · FY2020 · AG
Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration
$6,150,976Christopher Ramsden · National Institute On Aging · ZIA · FY2023 · AG
PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE
$6,131,561University Of Washington · U01 · FY2005 · AG
Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC)
$6,118,496Sudha Seshadri · University Of Texas Hlth Science Center · RF1 · FY2018 · AG
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
$6,115,044Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2022 · AG
Center for Alzheimer's and Related Dementias (CARD): iPSC Neurodegenerative Diseases Initiative
$6,108,838Andrew Singleton · National Institute On Aging · ZIA · FY2024 · AG
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD
$6,107,805E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2025 · AG
Long-Term Nicotine Treatment of Mild Cognitive Impairment
$6,088,879Paul A. Newhouse · Vanderbilt University Medical Center · R56 · FY2022 · AG
Alzheimer's Disease Cooperative Study (ADCS)
$6,081,533Paul S. Aisen · University Of California, San Diego · U01 · FY2012 · AG
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)
$6,072,987John Alam · Eip Pharma, Inc. · R01 · FY2025 · AG
Biomarker Evaluation in Young Onset Dementia from Diverse Populations (BEYONDD)
$6,065,228Adam L Boxer · University Of California, San Francisco · R56 · FY2022 · AG
A platform for cell type-level transcriptomic, epigenomic and spatial interrogation of Alzheimer's disease
$6,063,410Ed Lein · Allen Institute · U19 · FY2024 · AG
First stage single-cell brain resource for Alzheimer's disease and related dementias
$6,061,877Andrew Singleton · National Institute On Aging · ZIA · FY2023 · AG
Dominantly Inherited Alzheimer Network
$6,058,792Randall J Bateman · Washington University · U19 · FY2019 · AG
Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics
$6,054,626Ed Lein · Allen Institute · U19 · FY2023 · AG
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
$6,053,040Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2023 · AG
ITM 2.0: Advancing Translational Science in Metropolitan Chicago
$6,048,516Julian Solway · University Of Chicago · UL1 · FY2021 · TR